RESOURCE USE IN IDIOPATHIC PULMONARY FIBROSIS- INFLUENCE OF DISEASE PROGRESSION AND EXACERBATIONS

Author(s)

Diamantopoulos A¹, Schoof N², Esser D², LeReun C³
¹Symmetron Limited, Elstree, UK, ²Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany, ³Independent biostatistician, Guadeloupe, France

Presentation Documents

PRS69--strong-u-diamantopoulos-a-u-sup-1-sup-strong-schoof-n-sup-2-sup-esser-d-sup-2-sup-lereun-c-sup-3-sup-br-sup-1-sup-symmetron-limited-elstree-uk-sup-2-sup-boehringer-ingelheim-gmbh-ingelheim-am-rhein-germany-sup-3-sup-independent-biost ...

OBJECTIVES:

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PRS69

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic

Economic Evaluation